The open-label Phase 2 trial will evaluate ebribafusp for the treatment of IgA nephropathy, lupus nephritis and C3 ...

Vertiv (VRT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks ...

The FDA granted Breakthrough Therapy designation to Eli Lilly's olomorasib as a monotherapy for KRAS G12C-mutant advanced ...

Results land on Tuesday after-hours with data centre revenue expected to double and the sector in retreat Advanced Micro Devices Inc's (NASDAQ:AMD, XETRA:AMD) second-quarter print is the official ...

Shaires raises US$28.5m as it moves closer to unveiling its first portfolio of private AI and technology investments.

A grieving family mistakenly told they would inherit £30,000 in Premium Bonds by National Savings and Investments (NS&I) were ...

Senior Plc (LSE:SNR) said its proposed acquisition by a consortium backed by Tinicum and Blackstone remains on course to ...

The US and Japan have carried out their first joint yen-buying intervention since 1998. Traders are watching whether the move ...

Shares in AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) fell 7% to 11,723p on Monday after news that Britain's biggest drugmaker is in talks to buy its US rival, Bristol-Myers Squibb Co (NYSE:BMY, XETRA:RM, ...

EasyJet PLC (LSE:EZJ) has given private equity group Castlelake four more days to decide whether to make a firm takeover ...

Over 25 years, MSV-focused firms often underperformed and faced market discipline, while customer-obsessed firms like Amazon, ...

This ETF provides one-click access to 50 high-yielding UK dividend stocks, meaning it offers investors an easy way to ...